Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
immunotherapy
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
akcea therapeutics
amgen
cancer immunotherapy
fda
glaxosmithkline
medical devices
nonalcoholic steatohepatitis
todd shegog
vertex pharmaceuticals
What
roundup
bio
abbvie’s
according
advantages
ahead
akcea
bar
biofourmis
biotech
brings
bucks
cancer
cases
celebrate
centers
chance
cigarettes
control
corner
day
days
deaths
disease
drug
electronic
expect
forward
gamble
holiday
including
injuries
labor
linked
looking
lung
market
medco’s
mover
nash
Language
unset
3
×
Current search:
immunotherapy
×
unset
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone